Literature DB >> 28429464

Inflammatory features of frontal fibrosing alopecia.

Sophia A Ma1, Sotonye Imadojemu2, Kenneth Beer2,3, John T Seykora2.   

Abstract

INTRODUCTION: Frontal fibrosing alopecia (FFA) is a cicatricial alopecia typically occurring in postmenopausal women. The etiology and pathophysiology of FFA is poorly understood but thought to be immune mediated. This study aims to further explore the extent of fibrosis and the inflammatory microenvironment by characterizing Langerhans cells (LCs), helper T cells, cytotoxic T cells and B cells near hair follicles in FFA.
METHODS: Eleven paraffin-embedded tissues from patients with a clinical and histopathologic diagnosis of FFA were selected for immunohistochemical studies using CD3, CD4, CD8, CD1a and CD20. The lymphocytes and LCs were counted around involved follicles. The CD4/CD8 T-lymphocyte ratios were calculated and compared to the CD4/CD8 T-lymphocyte ratios in uninvolved areas.
RESULTS: On histopathologic review, at least 35% of follicles in each case were affected by the disease with concentric perifollicular fibrosis and a perifollicular lichenoid lymphocytic infiltrate around the infundibuloisthmic portion of the hair follicle. There was an increase of perifollicular LCs (mean of 18, SD of 5.5) and intrafollicular LCs (mean of 14, SD of 4.3) in involved follicles compared to uninvolved follicles (P < .0001). The involved follicles also showed a relative decrease in the CD4/CD8 ratio indicating increased numbers of CD8+ T cells; a finding distinct from the CD4-predominant population in uninvolved follicles (P < .0001).
CONCLUSION: The inflammatory features of FFA show a CD8-biased T-cell infiltrate with increased numbers of LCs in the infundibuloisthmic region. The increased LCs may represent an aberrant immune reaction promoting a CD8+ T-cell response.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CD8 T cell; frontal fibrosing alopecia; scarring alopecia

Mesh:

Substances:

Year:  2017        PMID: 28429464      PMCID: PMC6037423          DOI: 10.1111/cup.12955

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  28 in total

1.  The spectrum of histopathologic and immunohistochemical findings in folliculotropic mycosis fungoides.

Authors:  Pedram Gerami; Joan Guitart
Journal:  Am J Surg Pathol       Date:  2007-09       Impact factor: 6.394

2.  Glabellar red dots in frontal fibrosing alopecia: a further clinical sign of vellus follicle involvement.

Authors:  R Pirmez; A Donati; N S Valente; C T Sodré; A Tosti
Journal:  Br J Dermatol       Date:  2014-03       Impact factor: 9.302

3.  Langerhans' cells of the normal human pilosebaceous system. An electron microscopic investigation.

Authors:  K Jimbow; S Sato; A Kukita
Journal:  J Invest Dermatol       Date:  1969-02       Impact factor: 8.551

4.  The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin.

Authors:  J D Bos; I Zonneveld; P K Das; S R Krieg; C M van der Loos; M L Kapsenberg
Journal:  J Invest Dermatol       Date:  1987-05       Impact factor: 8.551

5.  Facial lesions in frontal fibrosing alopecia (FFA): Clinicopathological features in a series of 12 cases.

Authors:  Arantxa López-Pestaña; Anna Tuneu; Carmen Lobo; Nerea Ormaechea; José Zubizarreta; Susana Vildosola; Elena Del Alcazar
Journal:  J Am Acad Dermatol       Date:  2015-10-01       Impact factor: 11.527

Review 6.  The evolving function of Langerhans cells in adaptive skin immunity.

Authors:  Botond Z Igyarto; Daniel H Kaplan
Journal:  Immunol Cell Biol       Date:  2010-03-16       Impact factor: 5.126

7.  Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris.

Authors:  S Kossard; M S Lee; B Wilkinson
Journal:  J Am Acad Dermatol       Date:  1997-01       Impact factor: 11.527

8.  Topical tretinoin replenishes CD1a-positive epidermal Langerhans cells in chronically photodamaged human skin.

Authors:  G F Murphy; S Katz; A M Kligman
Journal:  J Cutan Pathol       Date:  1998-01       Impact factor: 1.587

9.  Frontal fibrosing alopecia: clinical presentations and prognosis.

Authors:  K T Tan; A G Messenger
Journal:  Br J Dermatol       Date:  2008-09-22       Impact factor: 9.302

10.  Lichen planopilaris: Epidemiology and prevalence of subtypes - a retrospective analysis in 104 patients.

Authors:  Johanna Meinhard; Andrea Stroux; Lena Lünnemann; Annika Vogt; Ulrike Blume-Peytavi
Journal:  J Dtsch Dermatol Ges       Date:  2014-02-17       Impact factor: 5.584

View more
  5 in total

1.  Characterization of the inflammatory features of central centrifugal cicatricial alopecia.

Authors:  Alexandra Flamm; Ata S Moshiri; Fritzlaine Roche; Ginikanwa Onyekaba; Jennifer Nguyen; Alaina J James; Susan Taylor; John T Seykora
Journal:  J Cutan Pathol       Date:  2020-03-06       Impact factor: 1.587

Review 2.  Frontal Fibrosing Alopecia: A Review.

Authors:  María Librada Porriño-Bustamante; María Antonia Fernández-Pugnaire; Salvador Arias-Santiago
Journal:  J Clin Med       Date:  2021-04-21       Impact factor: 4.241

Review 3.  Frontiers in Lichen Planopilaris and Frontal Fibrosing Alopecia Research: Pathobiology Progress and Translational Horizons.

Authors:  Maryanne Makredes Senna; Erik Peterson; Ivan Jozic; Jérémy Chéret; Ralf Paus
Journal:  JID Innov       Date:  2022-03-01

4.  Frontal Fibrosing Alopecia: A Histopathological Comparison of the Frontal Hairline with Normal-Appearing Scalp.

Authors:  María Librada Porriño-Bustamante; Fernando Javier Pinedo-Moraleda; Ángel Fernández-Flores; Trinidad Montero-Vílchez; María Antonia Fernández-Pugnaire; Salvador Arias-Santiago
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

5.  Association between frontal fibrosing Alopecia and Rosacea: Results from clinical observational studies and gene expression profiles.

Authors:  Lin Liu; Yangmei Chen; Jiayi Chen; Yuzhou Xue; Tingqiao Chen; Yuxin Li; Xinyi Shao; Jin Chen
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.